Insider trading

Period: 120 months Stock: EXEL Type of trade: Sold × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

399 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

399 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

399 decisions over 120 months Remove this filter
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

399 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
399 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
399 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

399 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
10 Aug 2026
Beckerle Mary C Director
Sold on a plan
$526.51K 9,812 at 53.66
37.9%
Planned (10b5-1)
1 Jun 2026
Sold on a plan
$491.97K 9,812 at 50.14
37.9%
Planned (10b5-1)
1 Jun 2026
Sold on a plan
$198.41K 3,925 at 50.55
1.4%
Planned (10b5-1)
26 May 2026
Aftab Dana EVP, Research and Development
Sold at will
$2.19M 43,451 at 50.35
6.8%
Not planned
20 May 2026
Haley Patrick J. EVP, Commercial
Sold at will
$1.60M 32,110 at 49.81
8.2%
Not planned
18 May 2026
Senner Christopher J. EVP and CFO
Sold at will
$1.75M 34,901 at 50.00
3.5%
Not planned
18 May 2026
Hefti Brenda SVP and General Counsel
Sold on a plan
$332.64K 6,625 at 50.21
5.8%
Planned (10b5-1)
7 May 2026
POSTE GEORGE Director
Sold at will
$2.74M 60,000 at 45.71
33.6%
Not planned
7 May 2026
Freire Maria C Director
Sold at will
$949.16K 20,634 at 46.00
17.0%
Not planned
7 May 2026
Beckerle Mary C Director
Sold at will
$373.65K 7,712 at 48.45
30.6%
Not planned
24 Feb 2026
Aftab Dana EVP, Research and Development
Sold at will
$2.13M 47,918 at 44.50
7.2%
Not planned
19 Feb 2026
Aftab Dana EVP, Research and Development
Sold at will
$1.32M 29,873 at 44.35
4.3%
Not planned
18 Feb 2026
Sold on a plan
$4.38M 99,574 at 44.01
26.2%
Planned (10b5-1)
18 Feb 2026
Smith Julie Director
Sold at will 2×
$2.85M 64,117 at 44.44
75.7%
Sold half or more
18 Feb 2026
Hefti Brenda SVP and General Counsel
Sold on a plan
$821.62K 18,669 at 44.01
16.2%
Planned (10b5-1)
17 Feb 2026
Haley Patrick J. EVP, Commercial
Sold at will 2×
$2.95M 67,814 at 43.52
15.1%
Not planned
17 Feb 2026
Smith Julie Director
Sold at will
$1.84M 42,422 at 43.33
67.3%
Sold half or more
17 Feb 2026
Senner Christopher J. EVP and CFO
Sold at will
$1.34M 30,617 at 43.67
3.0%
Not planned
13 Feb 2026
Senner Christopher J. EVP and CFO
Sold at will
$1.47M 34,278 at 43.00
3.2%
Not planned
13 Feb 2026
Oliver Bob Director
Sold at will 2×
$1.33M 30,250 at 43.81
58.9%
Sold half or more
13 Feb 2026
Sold on a plan
$168.85K 3,856 at 43.79
18.0%
Planned (10b5-1)
21 Nov 2025
Haley Patrick J. EVP, Commercial
Sold at will
$1.19M 28,043 at 42.58
7.0%
Not planned
20 Nov 2025
Haley Patrick J. EVP, Commercial · indirect
Sold at will 2×
$1.43M 34,187 at 41.88
100%
Sold half or more
20 Nov 2025
Haley Patrick J. EVP, Commercial
Sold at will
$421.10K 10,000 at 42.11
2.4%
Not planned
12 Nov 2025
Sold at will
$4.36M 100,000 at 43.55
7.8%
Not planned
11 Nov 2025
Aftab Dana EVP, Research and Development
Sold at will
$2.06M 48,383 at 42.50
6.8%
Not planned
11 Nov 2025
Beckerle Mary C Director
Sold at will 2×
$1.03M 24,622 at 41.93
53.5%
Sold half or more
3 Jun 2025
Sold on a plan
$324.68K 7,535 at 43.09
2.1%
Planned (10b5-1)
2 Jun 2025
Sold on a plan 2×
$805.14K 18,838 at 42.74
46.8%
Planned (10b5-1)
21 May 2025
Heyman Tomas J. Director
Sold at will
$201.25K 4,544 at 44.29
12.3%
Not planned
20 May 2025
Haley Patrick J. EVP, Commercial
Sold at will
$1.52M 34,387 at 44.06
7.7%
Not planned
16 May 2025
Senner Christopher J. EVP and CFO
Sold at will
$4.60M 100,000 at 46.00
9.4%
Not planned
16 May 2025
Peterson Amy C. EVP Prod Dev & Med Aff & CMO
Sold at will
$3.31M 72,776 at 45.47
13.5%
Not planned
16 May 2025
POSTE GEORGE Director
Sold at will
$948.96K 20,634 at 45.99
10.9%
Not planned
15 May 2025
Haley Patrick J. EVP, Commercial
Sold on a plan 2×
$6.06M 126,383 at 47.96
22.1%
Planned (10b5-1)
15 May 2025
Sold at will 2×
$1.62M 36,508 at 44.35
2.8%
Not planned
15 May 2025
Hessekiel Jeffrey EVP & General Counsel
Sold at will
$1.15M 25,000 at 46.18
3.5%
Not planned
14 May 2025
Haley Patrick J. EVP, Commercial
Sold on a plan
$426.80K 10,000 at 42.68
2.0%
Planned (10b5-1)
1 May 2025
Aftab Dana CSO/EVP Disc & Trans Research
Sold on a plan
$58.81K 1,508 at 39.00
0.2%
Planned (10b5-1)
3 Mar 2025
Haley Patrick J. EVP, Commercial
Sold on a plan
$388.00K 10,000 at 38.80
2.8%
Planned (10b5-1)
28 Feb 2025
Smith Julie Director
Sold at will
$725.84K 19,294 at 37.62
64.2%
Sold half or more
28 Feb 2025
Sold on a plan
$331.43K 8,768 at 37.80
2.4%
Planned (10b5-1)
27 Feb 2025
Smith Julie Director
Sold at will
$2.08M 54,514 at 38.13
83.5%
Sold half or more
25 Feb 2025
Oliver Bob Director
Sold at will
$694.60K 18,647 at 37.25
35.7%
Not planned
24 Feb 2025
Haley Patrick J. EVP, Commercial
Sold at will
$1.95M 52,636 at 36.98
14.8%
Not planned
24 Feb 2025
Senner Christopher J. EVP and CFO
Sold at will
$1.06M 29,314 at 36.14
3.6%
Not planned
24 Feb 2025
Aftab Dana CSO/EVP Disc & Trans Research
Sold at will
$991.77K 26,987 at 36.75
5.0%
Not planned
14 Feb 2025
Freire Maria C Director
Sold at will
$1.54M 44,114 at 34.94
32.6%
Not planned
14 Feb 2025
POSTE GEORGE Director
Sold at will
$551.46K 15,874 at 34.74
8.6%
Not planned
14 Feb 2025
Beckerle Mary C Director
Sold at will 2×
$425.88K 12,210 at 34.88
28.7%
Not planned
Showing 1–50 of 399. Page 1 of 8 Older →